ABL’s Bispecific Antibody For Parkinson's Lands In Sanofi’s Hands

$1bn Deal A CNS Leg Up For French Firm?

 
• By Jung Won Shin
  
partnership
Hefty Upfront, Near Term Milestones For ABL Bio • Source: Alamy

More from Deals

More from Business